氯吡格雷对大鼠肝药物酶CYP3A4 和CYP1A2 表达的影响

目的：氯吡格雷主要由CYP3A4 催化使其激活,CYP1A2 也参与氯吡格雷活化。关于氯吡格雷对肝微粒体酶的影响国内外文献报道不多,因此本实验通过检测肝细胞色素氧化酶CYP3A4 和CYP1A2 的表达,探讨氯吡格雷对大鼠肝药物酶的影响。方法：生理盐水为对照组,氯吡格雷设高、中、低三个剂量组（27,13.5,6.75mg/kg/d）,雄性健康大鼠连续灌胃给药7天,脱臼处死,取肝组织,通过western blot法检测大鼠肝脏CYP3A4 和CYP1A2 蛋白表达情况。结果：1）、氯吡格雷抑制大鼠CYP3A4 蛋白表达,氯吡格雷高中低剂量组分别比生理盐水组大鼠CYP3A4 蛋白表达量降低（P<0.05）;氯吡格雷低中高剂量组间进行比较,大鼠CYP3A4 蛋白表达量呈梯度减少（P<0.05）;2）、氯吡格雷抑制大鼠CYP1A2 蛋白表达,氯吡格雷高中低剂量组分别比生理盐水组大鼠CYP1A2 蛋白表达量降低（P<0.05）,氯吡格雷低中高剂量组间进行比较,大鼠CYP1A2 蛋白表达量呈梯度减少（P<0.05）。结论：氯吡格雷使肝细胞色素氧化酶CYP3A4 和CYP1A2 的表达量减少,因此氯吡格雷高、中、低3 个剂量组均不同程度的抑制大鼠肝脏CYP3A4 和CYP1A2 的表达,提示当氯吡格雷与某些主要经CYP3A4 和CYP1A2 代谢的药物合用时,发生代谢性相关作用的可能性大。     

应用TaqMan定量方法研究巴马香猪CYP1A1、2A19、2E1 mRNA表达

目的巴马香猪是我国具有特色和优势的实验用小型猪资源品系,用于药物评价具有广阔前景。方法 以β-actin作校正,利用TaqMan定量技术对巴马香猪肝、肾、肾上腺、小肠、皮肤、脑、肺、睾丸、前列腺、子宫和卵巢等组织中CYP1A1、2A19和2E1 mRNA的表达水平进行检测,检测结果与报道的人体对应酶CYP1A2、2A6、2E1进行比较。结果巴马香猪CYP1A1、2A19、2E1 mRNA均以肝脏中最高,肝外组织明显较低,并且巴马香猪肝脏CYP1A1、2A19、2E1 mRNA均低于报道的人肝对应酶。结论巴马香猪CYP1A1、2A19、2E1与人体对应酶CYP1A2、2A6、2E1的mRNA组织表达存在一定差异,提示在其作为相应CYP亚型代谢的药物评价时应考虑这种种属差异对实验结果推广到人的影响。     

应用寡核苷酸芯片并行检测CYP1A1和 GSTM1基因多态性

利用寡核苷酸芯片检测方法分析CYP1A1单核苷酸多态性 (SNP)和GSTM1缺失与否 ,实验结果证明了寡核苷酸芯片技术可并行、准确、高效地检测基因的单核苷酸多态性和其他类型的基因多态型 ,可为疾病遗传易感性及单体型的研究提供强有力的研究工具。采用该寡核苷酸芯片 ,检测了 84份正常人的血液DNA样本 ,其中GSTM1基因缺失率达到 4 7 6 % ,接近报道数值。统计分析发现 ,CYP1A1m1 m2的 3种基因型组合TT AG、TT GG和TC GG的发生频率都为 0 ,而根据实验得到的m1和m2各自基因型数据计算 ,它们的发生频率应是11 4 %、2 6 %和 3 1% ,所以推测在所检测的样本中没有T(m1位点 )和G(m2位点 )的连锁组合 ,即m1和m2位点的组合只有 3种单体型 :T A、C A和C G ,其发生频率分别是 6 9 6 %、7 7%和 2 2 6 %。     

水生双翅目昆虫监测水体重金属污染的研究

水生双翅目昆虫是监测水体重金属污染的理想对象。文章归纳用于监测重金属污染的水生双翅目昆虫的种类,重点介绍水生双翅目昆虫在重金属污染下外部形态、内部结构、生化及分子水平的变化,以及相关生物标志物的研究,为水生双翅目昆虫用于水体重金属污染的生物监测提供科学依据。     

氯吡格雷对大鼠肝药物酶CYP3A4和CYP1A2表达的影响

目的：氯吡格雷主要由CYP3A4催化使其激活,CYPlA2也参与氯吡格雷活化。关于氯吡格雷对肝微粒体酶的影响国内外文献报道不多,因此本实验通过检测肝细胞色素氧化酶CYP3A4和CYPlA2的表达,探讨氯吡格雷对大鼠肝药物酶的影响。方法：生理盐水为对照组,氯吡格雷设高、中、低三个剂量组（27,13．5,6．75mg／kg／d）,雄性健康大鼠连续灌胃给药7天,脱臼处死,取肝组织,通过westernblot法检测大鼠肝脏CYP3A4和CYPlA2蛋白表达情况。结果：1）、氯吡格雷抑制大鼠CYP3A4蛋白表达,氯吡格雷高中低剂量组分别比生理盐水组大鼠CYP3A4蛋白表达量降低（P〈0．05）;氯吡格雷低中高剂量组间进行比较,大鼠CYP3A4蛋白表达量呈梯度减少（P〈0．05）;2）、氯吡格雷抑制大鼠CYPlA2蛋白表达,氯吡格雷高中低剂量组分别比生理盐水组大鼠CYPlA2蛋白表达量降低（P〈0．05）,氯吡格雷低中高剂量组间进行比较,大鼠CYPlA2蛋白表达量呈梯度减少（P〈0．05）。结论：氯吡格雷使肝细胞色素氧化酶CYP3A4和CYPlA2的表达量减少,因此氯吡格雷高、中、低3个剂量组均不同程度的抑制大鼠肝脏CYP3A4和CYPlA2的表达,提示当氯吡格雷与某些主要经CYP3A4和CYPlA2代谢的药物合用时,发生代谢性相关作用的可能性大。     

迁人江淮稻区褐稻虱生物型跟踪监测及分析

该文对近年来褐稻虱迁入虫源的性质进行了探讨,结果表明迁入的虫源在鉴别品种Mudgo上的致害力,生存率、取食量和原始的种群生物型I没有明显的差别;两者在酯酶同工酶谱带数目和RF值也没有差异。迁入的虫源在田间抗性品种上明显表现虫量少。因此,迁入江淮稻区虫源仍是种群生物型I。人工在Mudgo上诱导产生的生物型1再回到感性品种上连续饲养8代,其对Mudgo的致害性降为1.O级,表明了褐稻虱生物型的不稳定性。     

西兰花CYP83A1基因的克隆及序列分析

为深入研究西兰花4-甲基亚磺酰丁基芥子油苷的合成代谢途径,对关键合成酶基因CYP83A1进行了克隆与生物信息学分析。根据前期西兰花转录组测序工作中获得的序列数据,同时参照Gen Bank数据库中拟南芥、小白菜和油菜等7种植物的CYP83A1基因CDS序列与西兰花进行比对,确定西兰花CYP83A1基因(Bo CYP83A1)的CDS序列。采用RT-PCR技术对其进行了克隆,获得Bo CYP83A1基因的CDS区序列,其全长为1 509 bp,编码502个氨基酸。预测该蛋白质的分子量为57.47 k D,理论等电点为7.1,包含2个跨膜结构域,且整个序列中不含信号肽,具有一个典型的P450结构域。氨基酸同源性分析表明,西兰花与油菜、大白菜的CYP83A1的相似性较高,均为98%。首次获得Bo CYP83A1的CDS序列,其登录号为KM111290。     

乙酰胆碱酯酶作为水体中杀虫剂污染生物标志物的评价与展望

随着"污染控制与治理为主的治理时代"运渐向"预防为主的环境管理时代"迈进,乙酰胆碱酯酶用于水体中杀虫剂污染的早期预警研究已成为生态毒理学的热门领域之一.本文以近年来该领域的研究成果为基础,指出了乙酰胆碱酯酶作为监测水体中杀虫剂污染生物标志物的特异敏感性优势,并针对该生物标志物应用过程中尚未解决的难题提出了今后的发展方向.     

3种海洋鱼类肝微粒体EROD活性的测定

根据鱼类的生态习性选择了暖温性近岸底层岩礁鱼类褐菖鲉和浅海底层鱼类黄鳍鲷和黑鲷作为实验动物,系统地研究了0#柴油WSF诱导组和对照组褐菖鲉肝微粒体EROD动力学反应系统的测定条件,确定了最适测定条件为:pH值7.60、温度15℃、底物7-乙氧基异吩恶唑浓度0.5μmol/L、样品蛋白量100—800μg、还原型辅酶II NADPH 70 nmol/mL。诱导组和对照组的最适反应条件没有差别,但是诱导组的酶活性比对照组的高;对照组和诱导组EROD的Km值分别为0.144μmol/L和0.357μmol/L,Vmax值分别为0.466 nmol min-1mg-1蛋白和2.360 nmol min-1mg-1蛋白。首次在我国建立了褐菖鲉肝微粒体EROD活性检测技术。此外,比较了上述3种实验鱼类肝微粒体EROD反应系统的最适pH值和最适温度。结果表明,与褐菖鲉不同,黄鳍鲷和黑鲷肝EROD反应最适pH值都是7.80,最适温度都是25℃。     

刺激隐核虫感染对褐菖鲉的胁迫及鱼体的免疫应答

为探明刺激隐核虫感染对褐菖鲉生理机能的影响,研究分别用2500、5000、7500和10000幼虫/鱼的刺激隐核虫感染褐菖鲉,并分别检测感染后24h、48h、72h和96h各时间点血清中皮质醇(COR)、血糖(GLU)、总蛋白(TP)含量;肝脏中丙二醛(MDA)和维生素C(VC)含量,超氧化物歧化酶(SOD)和过氧化氢酶(CAT)活力;鳃和皮肤中溶菌酶(LZM)活力。结果显示,随着感染浓度的增加,血液中COR和GLU含量均出现不同程度的升高,其中2500、5000和7500幼虫/鱼组COR含量的最高值均出现在感染后第3天;而TP含量总体呈现逐步下降的趋势,尤其当感染浓度达到5000幼虫/鱼后,TP含量的下降程度明显增加;肝脏中MDA含量呈先降后升的变化趋势,其中24h、48h和72h各点MDA含量的最大值均出现在10000幼虫/鱼组,最小值则集中出现于在2500和5000幼虫/鱼组;而VC含量则与MDA含量的趋势相反;SOD和CAT活力均出现不同程度的升高;鳃和皮肤LZM活力总体呈先上升后回落的变化趋势。综上可知,刺激隐核虫感染会对鱼体造成氧化胁迫和脂质过氧化反应,其严重程度与感染的虫细胞浓度相关。低浓度感染组的鱼所受胁迫较轻,在滋养体脱落后仍具有一定的自我修复能力;而高浓度感染组鱼免疫因子的释放受到抑制或出现紊乱,即便在虫体脱落后,其体质也很难恢复。     

Final steps in juvenile hormone biosynthesis in the desert locust, Schistocerca gregaria

Two genes coding for enzymes previously reported to be involved in the final steps of juvenile hormone (JH) biosynthesis in different insect species, were characterised in the desert locust, Schistocerca gregaria. Juvenile hormone acid O-methyltransferase (JHAMT) was previously described to catalyse the conversion of farnesoic acid (FA) and JH acid to their methyl esters, methyl farnesoate (MF) and JH respectively. A second gene, CYP15A1 was reported to encode a cytochrome P450 enzyme responsible for the epoxidation of MF to JH. Additionally, a third gene, FAMeT (originally reported to encode a farnesoic acid methyltransferase) was included in this study. Using q-RT-PCR, all three genes (JHAMT, CYP15A1 and FAMeT) were found to be primarily expressed in the CA of the desert locust, the main biosynthetic tissue of JH. An RNA interference approach was used to verify the orthologous function of these genes in S. gregaria. Knockdown of the three genes in adult animals followed by the radiochemical assay (RCA) for JH biosynthesis and release showed that SgJHAMT and SgCYP15A1 are responsible for synthesis of MF and JH respectively. Our experiments did not show any involvement of SgFAMeT in JH biosynthesis in the desert locust. Effective and selective inhibitors of SgJHAMT and SgCYP15A1 would likely represent selective biorational locust control agents.     

Characterization of human CYP1A1/1A2 induction by DNA microarray and alpha-naphthoflavone

DNA microarrays and real time PCR were used to analyze the mechanism of gene induction by CYP1A1 inducers, beta-naphthoflavone, and omeprazole, in the human hepatocellular carcinoma HepG2 cells. Reproducible and significant inductions were observed in a limited number of genes including CYP1A1 and CYP1A2. Genes induced by omeprazole included several protein tyrosine kinase targets. This result confirmed that omeprazole could modulate gene expressions through protein tyrosine kinase-mediated pathway. Induction ratios were considerably different from CYP1A1 and CYP1A2 (>10-fold) to other induced genes (<5-fold). alpha-Naphthoflavone, which is known as an antagonist to 2,3,7,8-tetrachlorodibenzo-p-dioxin, inhibited the inductions of heme oxygenase 1, glutamate-cysteine ligase (modifier unit), and thioredoxin reductase by beta-naphthoflavone but not those of CYP1A1 and CYP1A2. It unexpectedly enhanced the beta-naphthoflavone-mediated CYP1A1 and CYP1A2 induction. These results suggest that the CYP1A1 and CYP1A2 genes, which share their 5(') enhancer regions, are regulated differently from the other genes.     

Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma

Endogenous nitrosation due to chronic inflammation is enhanced in opisthorchiasis and plays a crucial role in the development of cholangiocarcinoma (CCA). Hepatic cytochrome P450 (CYP) family enzymes, especially CYP2A6 and CYP2E1, are involved in the metabolism of procarcinogens; these two enzymes metabolize endogenous nitrosamines to carcinogenic N-dimethylnitrosamine (NDMA). CYP2A6 activity is increased in patients infected with Opisthorchis viverrini. Our aim was to determine whether the expression and function of CYP2A6 and 2E1 in the livers of patients with O. viverrini-associated cholangiocarcinoma (CCA) was altered compared to livers without CCA. Livers of CCA patients (n = 13 cases) showed increased enzyme activities, protein and mRNA levels of CYP2A6 whereas the enzyme activity and protein levels of CYP2E1 were markedly decreased (P < 0.05). CYP2E1 mRNA levels were not altered. Large numbers of inflammatory cells and increased iNOS expression was found in areas adjacent to the tumor. The data provide evidence to support the concept that enhanced CYP2A6 activity and diminished CYP2E1 activity probably involve to the progression of CCA.     

Curcumin modulates drug metabolizing enzymes in the female Swiss Webster mouse

Curcumin, the yellow pigment found in turmeric, exhibits potent chemopreventative properties in both in vivo and in vitro cancer models. We hypothesized that this effect may occur via curcumin-mediated changes in enzymes involved in both carcinogen bioactivation and estrogen metabolism. Female Swiss Webster mice were treated with either curcumin (200 mg/kg or 400 mg/kg, p.o.) or vehicle control for 1 or 2 weeks. The results demonstrated that curcumin had no effect on the catalytic activities of ovarian aromatase, hepatic catechol-O-methyltransferase or hepatic UDP-glucuronosyltransferase. However, both doses of curcumin caused a 25% decrease in CYP1A catalytic activity, but not polypeptide levels, following 2 weeks of treatment. Additionally, following 2 weeks of curcumin at 400 mg/kg, there was a 20% decrease in the catalytic activity and a 28% decrease in polypeptide levels of CYP3A. While 2 weeks of curcumin treatment (400 mg/kg) caused a 20% increase in glutathione S-transferase activity, there was no parallel increase in hepatic stores of the co-factor glutathione. In conclusion small changes in CYP1A, CYP3A and GST following long term treatment (2 weeks) suggest that the combination of all three metabolic pathways may play a small role in curcumin's chemopreventative action.     

Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 by Streptomyces griseolus cytochrome P450SU-1

Streptomyces griseolus cytochrome P450SU-1 (CYP105A1) was expressed in Escherichia coli at a level of 1.0 micromol/L culture and purified with a specific content of 18.0 nmol/mg protein. Enzymatic studies revealed that CYP105A1 had 25-hydroxylation activity towards vitamin D2 and vitamin D3. Surprisingly, CYP105A1 also showed 1alpha-hydroxylation activity towards 25(OH)D3. As mammalian mitochondrial CYP27A1 catalyzes a similar two-step hydroxylation towards vitamin D3, the enzymatic properties of CYP105A1 were compared with those of human CYP27A1. The major metabolite of vitamin D2 by CYP105A1 was 25(OH)D2, while the major metabolites by CYP27A1 were both 24(OH)D2 and 27(OH)D2. These results suggest that CYP105A1 recognizes both vitamin D2 and vitamin D3 in a similar manner, while CYP27A1 does not. The Km values of CYP105A1 for vitamin D2 25-hydroxylation, vitamin D3 25-hydroxylation, and 25-hydroxyvitamin D3 1alpha-hydroxylation were 0.59, 0.54, and 0.91 microM, respectively, suggesting a high affinity of CYP105A1 for these substrates.